This follows from earlier studies identifying genetic mutations that are rare in the general population and predict risk of Mendelian (sub-types of) diseases with high sensitivity and specificity (for example BRCA1/2 in familial breast and ovarian cancer). The gene discussed is BRCA1; the disease is ovarian cancer.